La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Parkinson Disease, Secondary (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Parkinson Disease, Secondary (diagnostic imaging) < Parkinson Disease, Secondary (drug therapy) < Parkinson Disease, Secondary (enzymology)  Facettes :

List of bibliographic references indexed by Parkinson Disease, Secondary (drug therapy)

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
000727 (2015) Gaynor A. Smith [États-Unis] ; Emily M. Rocha [États-Unis] ; Thomas Rooney [France] ; Pascal Barneoud [France] ; Jesse R. Mclean [États-Unis] ; Jonathan Beagan [États-Unis] ; Teresia Osborn [États-Unis] ; Madeleine Coimbra [France] ; Yongyi Luo [États-Unis] ; Penelope J. Hallett [États-Unis] ; Ole Isacson [États-Unis]A Nurr1 Agonist Causes Neuroprotection in a Parkinson’s Disease Lesion Model Primed with the Toll-Like Receptor 3 dsRNA Inflammatory Stimulant Poly(I:C)
001F11 (2009) Dario Cuomo [France] ; Giuseppina Martella ; Emanuela Barabino ; Paola Platania ; Daniela Vita ; Graziella Madeo ; Chelliah Selvam ; Cyril Goudet ; Nadia Oueslati ; Jean-Philippe Pin ; Francine Acher ; Antonio Pisani ; Corinne Beurrier ; Christophe Melon ; Lydia Kerkerian-Le Goff ; Paolo GubelliniMetabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment.
002B82 (2005) Abid Oueslati [France] ; Nathalie Breysse ; Marianne Amalric ; Lydia Kerkerian-Le Goff ; Pascal SalinDysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism.
002F90 (2004) Roberto Coccurello [France] ; Nathalie Breysse [France] ; Marianne Amalric [France]Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats
003005 (2004) Christophe Jollivet [France] ; Anne Aubert-Pouessel [France] ; Anne Clavreul [France] ; Marie-Claire Venier-Julienne [France] ; Claudia N. Montero-Menei [France] ; Jean-Pierre Benoit [France] ; Philippe Menei [France]Long-term effect of intra-striatal glial cell line-derived neurotrophic factor-releasing microspheres in a partial rat model of Parkinson's disease
003650 (2001) Noelle Callizot [France] ; Jean-Louis Guénet [France] ; Caroline Baillet [France] ; Jean-Marie Warter [France] ; Philippe Poindron [France]The frissonnant Mutant Mouse, a Model of Dopamino-Sensitive, Inherited Motor Syndrome
003871 (2000) S. Aoyama [France] ; H. Kase ; E. BorrelliRescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist.
003878 (2000) R. Bordet [France] ; S. Ridray ; J C Schwartz ; P. SokoloffInvolvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats.
003879 (2000) P. Krack [France] ; P L Dowsey ; A L Benabid ; N. Acarin ; A. Benazzouz ; G. Künig ; K L Leenders ; J A Obeso ; P. PollakIneffective subthalamic nucleus stimulation in levodopa-resistant postischemic parkinsonism.
004081 (1998) Th Boraud [France] ; E. Bezard [France] ; D. Guehl [France] ; B. Bioulac [France] ; Ch Gross [France]Effects of l-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey
004089 (1998) Cristina Murer [France] ; Gustavo Dziewczapolski [Argentine] ; Liliana B. Menalled [Argentine] ; M. Carmen García [Argentine] ; Yves Agid [France] ; Oscar Gershanik [Argentine] ; Rita Raisman-Vozari [France]Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions
004192 (1997) P. Limousin [France] ; B. Memin ; P. PollakTreatment of dystonia occurring in parkinsonian syndromes by botulinum toxin.
004205 (1997) M. Vila [France] ; R. Levy ; M T Herrero ; M. Ruberg ; B. Faucheux ; J A Obeso ; Yves Agid [France] ; E C HirschConsequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA.
004459 (1997) E. Bezard [France] ; C. Imbert [France] ; X. Deloire [France] ; B. Bioulac [France] ; C. E. Gross [France]A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey
004478 (1996) P. Hantraye [France] ; E. Brouillet ; R. Ferrante ; S. Palfi ; R. Dolan ; R T Matthews ; M F BealInhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons.
004572 (1996) X. Picard [France] ; A. De Saint-Martin [France] ; E. Salmon [Belgique] ; E. Hirsch [France] ; C. Marescaux [France]Postencephalitic stereotyped involuntary movements responsive to L‐Dopa
004581 (1996) P. Barnéoud [France] ; M. Mazadier [France] ; J.-M. Miquet [France] ; S. Parmentier [France] ; P. Dubédat [France] ; A. Doble [France] ; A. Boireau [France]Neuroprotective effects of riluzole on a model of parkinson's disease in the rat
004A30 (1994) Chaodong Kastner [France] ; M. T. Herrero [France, Espagne] ; E. C. Hirsch [France] ; J. Guillen [Espagne] ; M. R. Luquin [Espagne] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; Yves Agid [France]Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP–intoxicated monkeys: Effect of levodopa and GM1 ganglioside therapy
004A75 (1994) A. Boireau [France] ; P. Dubedat ; F. Bordier ; C. Peny ; J.-M. Miquet ; G. Durand ; M. Meunier ; A. DobleRiluzole and experimental parkinsonism : antagonism of MPTP-induced decrease in central dopamine levels in mice
004A92 (1994) F. Tison [France] ; N. Fouillet ; P. HenryApomorphine increases blood glucose concentrations in Parkinson's disease
004C51 (1993) J. M. Senard [France] ; O. Rascol [France] ; A. Rascol ; J. L. Montastruc [France]Lack of yohimbine effect on ambulatory blood pressure recording : a double-blind cross-over trial in Parkinsonians with orthostatic hypotension

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Parkinson Disease, Secondary (drug therapy)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Parkinson Disease, Secondary (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease, Secondary (drug therapy)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024